In the next three decades, the world will have an extra 1.5 billion mouths to feed. That is a big challenge with current resources within the context of two simultaneous crises – one environmental, the other a so-called “double burden of malnutrition”, in which some two billion people are obese or overweight while a similar number suffer from insufficient access to nutrition.
Boosting crop yields
With limited scope to increase arable land, we need technology to boost productivity and yields. This is supported by EU and US policies to promote resource efficiency in agriculture while reducing the use of chemical pesticides and antimicrobials.Covid-19 has highlighted the link between poor diets and vulnerability to disease. Policymakers are pushing for reduced levels of sugar, salt and saturated fats while consumers are opting for foods and supplements offering benefits such as improved immunity.
MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
A growing number of companies are capitalising on the opportunity to feed the world in a healthy and sustainable manner. John Deere (NYSE: DE) is the world’s leading equipment manufacturer in the precision-agriculture sector. Appetite for new equipment is high given an ageing fleet (the oldest it has been in 30 years) and a growing awareness of the economic and environmental benefits of precision agriculture. Profitability in farming has returned to levels last seen in the 2011-2014 supercycle given high crop prices and strong harvests, making equipment upgrades more affordable.
A pet-health provider in pole position
In animal health, Zoetis (NYSE: ZTS), the biggest producer of medical treatments for pets and livestock, is well positioned to capitalise on market growth given its broad portfolio of blockbuster drugs, world-class manufacturing operations, speed to market and innovation capabilities. Its diagnostics business adds a new layer of superior growth and recurring revenues, allowing for preventative care of animals. US-based Zoetis has best-in-class margins among its peers and should continue to expand thanks to operating leverage and pricing power from innovation.
Finally, in the nutrition sector, DSM (Amsterdam: DSM) stands out for particularly innovative products. For humans, these include dietary supplements, fermented stevia (tastier, healthier versions of traditional sweeteners) and human-milk oligosaccharides (a collection of carbohydrate structures that may help support immunity and gut health).
The Dutch firm also specialises in animal nutrition, as its headline-grabbing “Clean Cow” initiative demonstrates. It involves the addition of a feed supplement that DSM says can reduce the amount of methane cows release into the air by at least 30%. The innovative portfolio of products, together with underlying portfolio organic growth, should underpin double-digit medium-term earnings growth.
• Mayssa Al Midani was recently a guest on the MoneyWeek Podcast. Listen to the episode here
-
Highest value stocks and shares ISAs worth 17 times more than cashAhead of potential ISA reforms in the Budget, new FOI data highlights the significant gap between saving and investing your yearly tax-free allowance
-
1 million pensioners relying solely on state pension face £1.4k shortfallThe shortfall between the ‘minimum’ required for Pensions UK’s basic Retirement Living Standards and the full new state pension will be thrust into the spotlight on Saturday
-
Who is Jared Isaacman, SpaceX astronaut and Trump's pick as NASA chief?Jared Isaacman is a close ally of Elon Musk and the first non-professional astronaut to walk in space. Now, he is in charge of NASA
-
Three solid British stocks going cheapOpinion Ian Lance and Nick Purves, fund managers at Temple Bar Investment Trust, highlight three British stocks with strong cash flows and robust balance sheets
-
Is now a good time to invest in Barclays?Barclays' profit growth is healthy, and the stock is cheap compared with its rivals
-
Profit from other investors’ trades with CME GroupCME Group is one of the world’s largest exchanges, which gives it a significant competitive advantage
-
Key lessons from the MoneyWeek Wealth Summit 2025: focus on safety, value and growthOur annual MoneyWeek Wealth Summit featured a wide array of experts and ideas, and celebrated 25 years of MoneyWeek
-
Defeat into victory: the key to Next CEO Simon Wolfson's successOpinion Next CEO Simon Wolfson claims he owes his success to a book on military strategy in World War II. What lessons does it hold, and how did he apply them to Next?
-
Aircraft leasing companies can lift investors' portfoliosThe aircraft leasing business is a safer way to cash in on air travel and its booming demand. David Prosser explains how it works and how to access it
-
8 of the best houses for sale with fishing rightsThe best houses for sale with fishing rights – from a Georgian property on the banks of the River Derwent, County Durham, to a restored mill house in Marlborough with fishing rights on the River Kennet
